Lincoln Pharmaceuticals Ltd vs Sai Parenterals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 636.2 as of 15 Jun 12:26 . The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 7.2 on March 2021 to 13.4 on March 2025 . This represents a CAGR of 13.23% over 5 yearsThe P/E Ratio of Sai Parenterals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 449.4 crore on March 2021 to ₹ 1104 crore on March 2025 . This represents a CAGR of 19.71% over 5 yearsThe Market Cap of Sai Parenterals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Lincoln Pharmaceuticals Ltd for the Mar '26 is ₹ 183.08 crore as compare to the Dec '25 revenue of ₹ 181.47 crore. This represent the growth of 0.89% The revenue of Sai Parenterals Ltd for the Mar '26 is ₹ 200.81 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Lincoln Pharmaceuticals Ltd for the Mar '26 is ₹ 20.66 crore as compare to the Dec '25 ebitda of ₹ 38.74 crore. This represent the decline of -46.67% The ebitda of Sai Parenterals Ltd for the Mar '26 is ₹ 28.97 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 23.67 crore to ₹ 11.63 crore over 8 quarters. This represents a CAGR of -29.90% The net profit of Sai Parenterals Ltd changed from ₹ -6.66 crore to ₹ 13.16 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 4.83 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of -1.94% over 5 yearsThe Dividend Payout of Sai Parenterals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
All the assets and business of the erstwhile partnership were transferred to the Company.
The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

FAQs for the comparison of Lincoln Pharmaceuticals Ltd and Sai Parenterals Ltd

Which company has a larger market capitalization, Lincoln Pharmaceuticals Ltd or Sai Parenterals Ltd?

Market cap of Lincoln Pharmaceuticals Ltd is 1,271 Cr while Market cap of Sai Parenterals Ltd is 2,505 Cr

What are the key factors driving the stock performance of Lincoln Pharmaceuticals Ltd and Sai Parenterals Ltd?

The stock performance of Lincoln Pharmaceuticals Ltd and Sai Parenterals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lincoln Pharmaceuticals Ltd and Sai Parenterals Ltd?

As of June 15, 2026, the Lincoln Pharmaceuticals Ltd stock price is INR ₹635.05. On the other hand, Sai Parenterals Ltd stock price is INR ₹567.15.

How do dividend payouts of Lincoln Pharmaceuticals Ltd and Sai Parenterals Ltd compare?

To compare the dividend payouts of Lincoln Pharmaceuticals Ltd and Sai Parenterals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.